Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A 18F-fluorodeoxyglucose study of a mouse model of atherosclerosis and type 2 diabetes

MLA

Johanna M. U. Silvola, et al. “Effects of Dipeptidyl Peptidase 4 Inhibition on Inflammation in Atherosclerosis: A 18F-Fluorodeoxyglucose Study of a Mouse Model of Atherosclerosis and Type 2 Diabetes.” Atherosclerosis, vol. 305, July 2020, pp. 64–72. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2020.03.029.

APA

Johanna M. U. Silvola, Pirjo Nuutila, Jenni Virta, Antti Saraste, Juhani Knuuti, Mirva Söderström, Heidi Liljenbäck, Mia Ståhle, Sanna Hellberg, Maria F. Gomez, Jenni Huusko, Seppo Ylä-Herttuala, & Anne Roivainen. (2020). Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A 18F-fluorodeoxyglucose study of a mouse model of atherosclerosis and type 2 diabetes. Atherosclerosis, 305, 64–72. https://doi.org/10.1016/j.atherosclerosis.2020.03.029

Chicago

Johanna M. U. Silvola, Pirjo Nuutila, Jenni Virta, Antti Saraste, Juhani Knuuti, Mirva Söderström, Heidi Liljenbäck, et al. 2020. “Effects of Dipeptidyl Peptidase 4 Inhibition on Inflammation in Atherosclerosis: A 18F-Fluorodeoxyglucose Study of a Mouse Model of Atherosclerosis and Type 2 Diabetes.” Atherosclerosis 305 (July): 64–72. doi:10.1016/j.atherosclerosis.2020.03.029.